With every price hike Mylan makes, another child will go without an EpiPen. In some cases, these families will end up in the emergency room…if they are lucky.
More than 700,000 petition signatures were delivered to Mylan corporate headquarters demanding that Mylan stop price gouging American consumers.
Last week, I gave an interview with Fox Business in which we discuss the skyrocketing price of EpiPens, Mylan’s monopoly and their 90% market share in the epinephrine auto-injector space. In the days that followed, Mylan was first silent and then appeared “frustrated.” In response to an onslaught of negative press, the company is now offering…
Mylan, the company that markets the EpiPen, is about to become much more well known in ways their CEO never imagined.
Please meet my friend, Kelly. She’s a single mom of five who just resigned as a spokesperson for EpiPen.
These images show the pricing practices of Mylan Pharmaceuticals that are placing the life-saving EpiPen out of reach of many families.
Senate Judiciary Committee Chairman Chuck Grassley (R-Iowa) is asking the CEO of Mylan, the maker of EpiPens, to explain sharp increases in the device’s price.
The explosive growth of food allergies has made EpiPen a billion-dollar brand.
The pricing practices of Mylan Pharmaceuticals are placing the life-saving EpiPen out of reach of many families and putting people’s lives at risk.
This Monsanto-backed bill was packaged as a “reasonable” way to label GMOs, but it actually infringes on states’ rights by preempting local laws and allows corporations to hide information using QR codes.